NOAC Monotherapy Wins in Afib with Drug Eluting Stents: Safer, Stronger, Smarter ⚖️🔥🧠
Dr RR Baliga's "Got Knowledge Doc" Podkast
November 13, 20253m 2s
Audio is streamed directly from the publisher (traffic.libsyn.com) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.
Show Notes
📢 ADAPT AF-DES Trial — A Safer Path Forward!
In patients with atrial fibrillation beyond 1 year after drug-eluting stent implantation, NOAC monotherapy delivered striking benefits over combination therapy.
✅ Lower net adverse clinical events
✅ Marked reduction in major/CRNM bleeding
✅ Similar ischemic protection
A beautifully simple strategy with meaningful impact.
Published in NEJM (2025).
💊🛡️📉💓